Search Results - "Luo, Qingquan"

The surgical perspective in neoadjuvant immunotherapy for resectable non-small cell lung cancer by Jiang, Long, Huang, Jia, Jiang, Shanshan, Rong, Wenwen, Shen, Yaofeng, Li, Chongwu, Tian, Yu, Ning, Junwei, Chen, Xiaoke, Yang, Yunhai, Ding, Zhengping, Li, Ziming, Luo, Qingquan

“…Background The recent novel conception of neoadjuvant immunotherapy has generated interest among surgeons worldwide, especially the lack of experience…”
Get full text

Thoracoscopic Surgery Versus Thoracotomy for Lung Cancer: Short-Term Outcomes of a Randomized Trial by Long, Hao, Tan, Qunyou, Luo, Qingquan, Wang, Zheng, Jiang, Gening, Situ, Dongrong, Lin, Yongbin, Su, Xiaodong, Liu, Qing, Rong, Tiehua

“…Safety and short-term efficacy of video-assisted thoracoscopic surgery (VATS) for early-stage non-small lung cancer (NSCLC) has been demonstrated by…”
Get full text

Biocompatible and Long-Term Monitoring Strategies of Wearable, Ingestible and Implantable Biosensors: Reform the Next Generation Healthcare by Lu, Tian, Ji, Shourui, Jin, Weiqiu, Yang, Qisheng, Luo, Qingquan, Ren, Tian-Ling

“…Sensors enable the detection of physiological indicators and pathological markers to assist in the diagnosis, treatment, and long-term monitoring of diseases,…”
Get full text

Review of surgical robotic systems for keyhole and endoscopic procedures: state of the art and perspectives by Chen, Yuyang, Zhang, Shu'an, Wu, Zhonghao, Yang, Bo, Luo, Qingquan, Xu, Kai

“…Minimally invasive surgery, including laparoscopic and thoracoscopic procedures, benefits patients in terms of improved postoperative outcomes and short…”
Get full text

Plasma miR-145, miR-20a, miR-21 and miR-223 as novel biomarkers for screening early-stage non-small cell lung cancer by Zhang, Hui, Mao, Feng, Shen, Tuyang, Luo, Qingquan, Ding, Zhengping, Qian, Liqiang, Huang, Jia

“…Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality in the world. Late diagnosis is one of the most significant reasons for the…”
Get full text

The multifaceted role of MUC1 in tumor therapy resistance by Jin, Weiqiu, Zhang, Mengwei, Dong, Changzi, Huang, Lei, Luo, Qingquan

“…Tumor therapeutic resistances are frequently linked to the recurrence and poor prognosis of cancers and have been a key bottleneck in clinical tumor treatment…”
Get full text

MAT1A activation of glycolysis to promote NSCLC progression depends on stabilizing CCND1 by Shen, Shengping, Liu, Ruili, Huang, Jiazheng, Sun, Yingjia, Tan, Qiang, Luo, Qingquan, Liu, Ruijun

“…Non-small cell lung cancer (NSCLC) remains a cause for concern as the leading cause of cancer-related death worldwide. Amidst ongoing debates on the role and…”
Get full text

SIRT6 drives epithelial-to-mesenchymal transition and metastasis in non-small cell lung cancer via snail-dependent transrepression of KLF4 by Li, Ziming, Huang, Jia, Shen, Shengping, Ding, Zhenping, Luo, Qingquan, Chen, Zhiwei, Lu, Shun

“…Epithelial-to-mesenchymal transition (EMT) contributes to the invasion and metastasis of epithelial tumors. Sirtuin 6 (SIRT6), an NAD-dependent deacetylase, is…”
Get full text

shRNA‑mediated knockdown of KNTC1 inhibits non-small-cell lung cancer through regulating PSMB8 by Liu, Ruijun, Liu, Ruili, Guo, Zhiyi, Ren, Jianghao, Huang, Jia, Luo, Qingquan, Tan, Qiang

“…In view of the important roles played by Kinetochore proteins in mitosis, we believed that they may contribute to the development and progression of human…”
Get full text

Artificial intelligence-assisted quantitative CT parameters in predicting the degree of risk of solitary pulmonary nodules by Jiang, Long, Zhou, Yang, Miao, Wang, Zhu, Hongda, Zou, Ningyuan, Tian, Yu, Pan, Hanbo, Jin, Weiqiu, Huang, Jia, Luo, Qingquan

“…Artificial intelligence (AI) shows promise for evaluating solitary pulmonary nodules (SPNs) on computed tomography (CT). Accurately determining cancer…”
Get full text

C/EBPδ-Slug-Lox1 axis promotes metastasis of lung adenocarcinoma via oxLDL uptake by Wang, Dongmei, Cheng, Xinghua, Li, Yu, Guo, Mingwei, Zhao, Wenjun, Qiu, Jin, Zheng, Ying, Meng, Meiyao, Ping, Xiaodan, Chen, Xin, Wang, Shu, Luo, Jian, Luo, Qingquan, Ma, Xinran, Xu, Lingyan

“…Cancer cells undergo significant lipid metabolic reprogramming to ensure sufficient energy supply for survival and progression. However, how cancer cells…”
Get full text

The learning curve on uniportal video-assisted thoracoscopic lobectomy with the help of postoperative review of videos by Song, Zuodong, Yuan, Yu, Cheng, Chao, Luo, Qingquan, Cheng, Xinghua

“…Video-assisted thoracoscopic lobectomy has become the preferred surgical approach in experienced centers, and uniportal approaches are becoming increasingly…”
Get full text

Oxidized low density lipoprotein receptor 1 promotes lung metastases of osteosarcomas through regulating the epithelial-mesenchymal transition by Jiang, Long, Jiang, Shanshan, Zhou, Wenjie, Huang, Jia, Lin, Yongbin, Long, Hao, Luo, Qingquan

“…Oxidized low density lipoprotein receptor 1 (OLR1), a type II membrane protein, has been identified as receptor for oxidized low-density lipoprotein. The…”
Get full text

Retraction Note: SIRT6 drives epithelial-to-mesenchymal transition and metastasis in non-small cell lung cancer via snail-dependent transrepression of KLF4 by Li, Ziming, Huang, Jia, Shen, Shengping, Ding, Zhenping, Luo, Qingquan, Chen, Zhiwei, Lu, Shun

Get full text

Propensity score-matched comparison of robotic- and video-assisted thoracoscopic surgery, and open lobectomy for non-small cell lung cancer patients aged 75 years or older by Pan, Hanbo, Gu, Zenan, Tian, Yu, Jiang, Long, Zhu, Hongda, Ning, Junwei, Huang, Jia, Luo, Qingquan

“…Introduction Although robot-assisted thoracoscopic surgery (RATS) has been widely applied in treating non-small cell lung cancer (NSCLC), its advantages remain…”
Get full text

Non-linear modifications enhance prediction of pathological response to pre-operative PD-1 blockade in lung cancer: A longitudinal hybrid radiological model by Jin, Weiqiu, Tian, Yu, Xuzhang, Wendi, Zhu, Hongda, Zou, Ningyuan, Shen, Leilei, Dong, Changzi, Yang, Qisheng, Jiang, Long, Huang, Jia, Yuan, Zheng, Ye, Xiaodan, Luo, Qingquan

“…Major pathologic remission (MPR, residual tumor <10%) is a promising clinical endpoint for prognosis analysis in patients with lung cancer receiving…”
Get full text

Comprehensive analysis of circular RNA profiling in AZD9291‐resistant non‐small cell lung cancer cell lines by Chen, Tianxiang, Luo, Jizhuang, Gu, Yu, Huang, Jia, Luo, Qingquan, Yang, Yunhai

“…Background Osimertinib (AZD9291), a third‐generation EGFR‐tyrosine kinase inhibitor, can effectively prolong survival in non‐small cell lung cancer (NSCLC)…”
Get full text

Trim44 facilitates the migration and invasion of human lung cancer cells via the NF-κB signaling pathway by Luo, Qingquan, Lin, Hao, Ye, Xiangyun, Huang, Jia, Lu, Shun, Xu, Lin

“…Background Trim44 is an important member of the tripartite motif-containing protein (TRIM) family. Recent research reported that Trim44 might play an important…”
Get full text

Homologous recombination deficiency (HRD) can predict the therapeutic outcomes of immuno-neoadjuvant therapy in NSCLC patients by Zhou, Zhen, Ding, Zhengping, Yuan, Jie, Shen, Shengping, Jian, Hong, Tan, Qiang, Yang, Yunhai, Chen, Zhiwei, Luo, Qingquan, Cheng, Xinghua, Yu, Yongfeng, Niu, Xiaomin, Qian, Liqiang, Chen, Xiaoke, Gu, Linping, Liu, Ruijun, Ma, Shenglin, Huang, Jia, Chen, Tianxiang, Li, Ziming, Ji, Wenxiang, Song, Liwei, Shen, Lan, Jiang, Long, Yu, Zicheng, Zhang, Chao, Tai, Zaixian, Wang, Changxi, Chen, Rongrong, Carbone, David P, Xia, Xuefeng, Lu, Shun

“…Neoadjuvant immunotherapy is emerging as novel effective intervention in lung cancer, but study to unearth effective surrogates indicating its therapeutic…”
Get full text

Cancer Burden Variations and Convergences in Globalization: A Comparative Study on the Tracheal, Bronchus, and Lung (TBL) and Liver Cancer Burdens Among WHO Regions from 1990 to 2019 by Zhang Mengwei, Jin Weiqiu, Tian, Yu, Zhu Hongda, Zou Ningyuan, Jia Yunxuan, Long, Jiang, Huang, Jia, Hu, Yingjie, Luo Qingquan

“…Lung cancer and liver cancer are the leading and third causes of cancer death, respectively. Both lung and liver cancer are with clear major risk factors. A…”
Get full text